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The use of antimicrobial agents in the veterinary ﬁeld aﬀects the emergence, prevalence, and dissemination of antimicrobial
resistance in bacteria isolated from food-producing animals. To control the emergence, prevalence, and dissemination of
antimicrobial resistance, it is necessary to implement appropriate actions based on scientiﬁc evidence. In Japan, the Japanese
Veterinary Antimicrobial Resistance Monitoring System (JVARM) was established in 1999 to monitor the antimicrobial
susceptibility of foodborne and commensal bacteria from food-producing animals. The JVARM showed that the emergence and
prevalence of resistant Escherichia coli were likely linked to the therapeutic antimicrobial use in food-producing animals through
not only direct selection of the corresponding resistance but also indirect selections via cross-resistance and coresistance. In
addition,relevantfactorssuchashostanimalsandbacterialpropertiesmightaﬀecttheoccurrenceandprevalenceofantimicrobial-
resistant E. coli under the selective pressure from antimicrobial usage. This paper reviews the trends in antimicrobial resistance
in E. coli and consumption of antimicrobials agents in Japan and introduces the relationship between antimicrobial usage and
prevalence of antimicrobial-resistant bacteria, from food-producing animals under the JVARM program. In this paper, we will
provide the underlying information about the signiﬁcant factors that can help control antimicrobial resistance in bacteria in
veterinary medicine.
1.Introduction
Antimicrobialagentsareessentialfortheprevention,control,
and treatment of bacterial infections in animals and are
also still used for growth promotion in animal husbandry
in many countries [1, 2]. The use of antimicrobial agents,
however, can cause the emergence, prevalence, and dissemi-
nation of antimicrobial resistance in bacteria. The eﬀect on
human health has been a concern since Swann et al. reported
that antimicrobial-resistant bacteria, arising from the use of
veterinary antimicrobial agents, were transmitted to humans
through livestock products and reduced the eﬃcacy of
antimicrobial drugs in humans [3]. The development of
antimicrobial resistance in bacteria of animal origin reduces
the eﬃcacy of veterinary antimicrobial drugs [1, 4]. Thus far,
these issues have been addressed by relevant international
organizations including the Food and Agriculture Organiza-
tion (FAO), International Committee of Oﬃce International
des Epizooties (OIE), World Health Organization (WHO),
and Codex, as described elsewhere [5, 6].
In response to the establishment of OIE international
standards [7] and FAO/OIE/WHO recommendations [8, 9],
monitoring systems for antimicrobial resistance in bacteria
isolatedfromfood-producinganimalswerecreatedinseveral
countries. In Japan, the Japanese Veterinary Antimicrobial
Resistance Monitoring System (JVARM) was established in2 Journal of Biomedicine and Biotechnology
1999 to study trends in resistance and associations between
usage of antimicrobial agents and resistance and to provide
data for risk assessment and management [10]. The JVARM
is based on three categories of bacteria—animal pathogens,
which are in general derived from diseased animals, and
zoonotic and commensal bacteria, which are derived from
fecal samples of apparently healthy animals.
Trends in antimicrobial resistance in bacteria are closely
related to the use of antimicrobial agents in veterinary
medicine [1, 4]. In reality, however, there are several factors
that participate in the association between the usage of
antimicrobials and the presence of antimicrobial resistance.
The factors aﬀecting the occurrence, prevalence, and dissem-
ination of resistance should be identiﬁed in each country
to implement appropriate actions to limit the emergence,
prevalence, and dissemination of antimicrobial resistance
and the improvement of human and animal health. The
present paper outlines the trend in antimicrobial resistance
in E. coli in Japan. In addition, it also reviews the signiﬁcant
factors that can inﬂuence the prevalence of antimicrobial
resistance in bacteria, mainly E. coli isolates from food-
producing animals under the JVARM program.
2. VeterinaryUse of AntimicrobialAgents
andAntimicrobialResistance inCommensal
E. coli Isolated from Food-Producing
AnimalsinJapan
2.1. The Usage Volume of Veterinary Antimicrobial Drugs
and Feed Additives. In Japan, antimicrobial agents in food-
producing animals have been used as (1) veterinary medical
products for treating an animal, or group of animals that
exhibit(s) evident clinical disease, and (2) feed additives for
growing animals by improving their physiological perfor-
mance [11, 12]. Under the laws and regulations, the former
products are either administered or sold to the end user
by veterinary practitioners, or purchased by farmers/animal
owners according to veterinary prescription, whereas the
latterproductspremixedwithanimalfeedstuﬀarepurchased
by farmers/animal owners from animal feed companies.
The usage volumes of antimicrobial drugs and feed
additives have been separately calculated in Japan. The use
of veterinary antimicrobial drugs was started in 1960s. Since
2000,pharmaceuticalcompaniesthatproduceand/orimport
antimicrobials for animals are required to submit data on the
annual sales volume (weight of active compound) by sub-
stance, class, and animal species, under the Pharmaceutical
Aﬀairs Law.
The sales volume of veterinary medical products from
2000 to 2005 is shown in Figure 1. The total antimicrobial
consumption of animals increased temporarily from 2000
(970tons) to 2001 (1060tons) and since then decreased to
870tonsin2005.Tetracyclinesremainedthemostcommonly
used antimicrobials in the veterinary ﬁeld (average of
417tons), followed by sulfonamides (145tons), macrolides
(103tons), penicillins (92tons), aminoglycosides (62tons),
and phenicols (23tons). These consumptions tend to be
greater in pigs and poultry, and lesser in cattle. On the other
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Figure 1: Trends in veterinary antimicrobials sold from pharmacies
in Japan.
hand, the consumption volume of ﬂuoroquinolones and
cephalosporins, which are regarded as critically important
antimicrobials in human medicine [13], was estimated to be
smaller(averageof6.5and2.4tons,resp.).Anestimated54%
of the total antimicrobial consumption by animal species
has been used for pigs, followed by poultry, and cattle
(approximately 16% and 8%, resp.) [11].
The use of antimicrobial feed additives was started in
1950s. In Japan, all antimicrobial feed additives must be
subjected to the national assay before distribution. The
current trends in assay acceptable amounts of feed additives
(converted to bulk products) are shown in Figure 2.F r o m
2000 to 2005, the total volume was fairly constant, averaging
171 tons. Polyethers and polypeptides comprised a large
percentageoffeedadditives(averageof97and44tons,resp.),
whereas those of other compounds, including tetracyclines,
aminoglycosides, and macrolides, comprised less than 5% of
the total volume (average of 6.8, 5.0, and 1.1 tons, resp.).
Presently, the total usage volume of antimicrobial drugs
is much greater than that of antimicrobial feed additives
in Japan. Thus, veterinary antimicrobial drugs are given
priority asriskfactorsassociatedwithbacterialantimicrobial
resistance.Journal of Biomedicine and Biotechnology 3
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Figure 2: Trends in assay acceptable amounts of antimicrobial feed
additives in Japan.
2.2. Relationship between the National Overall Usage Vol-
ume of Therapeutic Antimicrobials and the Prevalence of
Antimicrobial-Resistant Bacteria. Few studies have provided
an overview of the correlation between the usage vol-
ume of veterinary antimicrobials and the resistance rates
among bacteria isolated from food-producing animals. In
Japan, it was shown that the prevalence of resistance to
a certain antimicrobial class among commensal E. coli
isolates increased proportionately with the overall usage of
the relevant class of drugs in each animal species [14].
When using data obtained from the DANMAP reports, the
correlation was also represented between the usage volume
of antimicrobial agents and the resistant population in E.
coli observed in cattle and pigs [15]. Therefore, the national
overall usage volume of therapeutic antimicrobials is likely
to be related to the occurrence of antimicrobial resistance
among commensal E. coli isolates from food-producing
animals.
2.3. The Prevalence of Antimicrobial Resistance Linked with
Species of Host Animal. In Japan, penicillins, tetracyclines,
and streptomycins were classically approved and have been
commonly used in animal husbandry for long periods.
Figure 3 shows the current trends in resistances to these
classical antimicrobials among commensal E. coli from food-
producing animals in Japan. From 2000 to 2007, the rates
of resistances to these antimicrobials were stable in all three
animal species, indicating that there is no signiﬁcant change
in the current usage volume of antimicrobials in food-
producing animals.
Comparison of the average resistance rates through the
yearsrevealedthattherateofampicillinresistancewas46.0%
in broilers, followed by pigs (27.3%), and cattle (10.8%). On
the other hand, tetracycline and streptomycin resistance has
beenmorefrequentlyobservedinbroilers(63.2%and45.9%,
resp.) and pigs (65.5% and 52.7%, resp.), as compared with
that in cattle (31.4% and 23.6%, resp.). Overall, the levels
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Figure 3: Trends in resistance to selected antimicrobials among
commensal E. coli isolates from cattle, pigs, and broiler chickens in
Japan.
of resistance are apparently diﬀerent between animal species
and, in particular, resistance was less prevalent in cattle than
in pigs and broilers.
The use of chloramphenicol in food-producing animals
was banned in 1998 in Japan [16]. Nevertheless, current
monitoring data shows that chloramphenicol resistance is
still prevalent in pigs (average of 20.2%), followed by
chickens (12.3%), and cattle (3.2%). Thiamphenicol and
ﬂorfenicol, which belong to the same family as chloram-
phenicol, are administered to food-producing animals with
diﬀerent usage volumes among animal species (pigs >
chickens>cattle).Theuseoftheseantimicrobialsmaybeone
factor causing the persistence of chloramphenicol resistance
[16].
Overall, the levels of resistance to antimicrobials vary by
animal species, and can be primarily aﬀected by the usage4 Journal of Biomedicine and Biotechnology
volume of antimicrobials in each species [14]. Lower resis-
tance levels of bacteria in cattle than in pigs and broilers have
been commonly observed in case of all the antimicrobials,
and this trend has remained largely unchanged since the
start of monitoring [17–19]. In Japan, pigs and chickens
are usually housed under relatively intensive conditions,
whereas cattle are generally less intensively reared. In pigs or
chickens, all the animals in the group or ﬂock are preferably
treated via feed or water because one can anticipate that
infections will spread among multiple animals in the group
or ﬂock. On the other hand, in cattle, antimicrobials are
usually administered orally or by injection to each aﬀected
animal. Thus, such animal species-speciﬁc management
system probably produces the diﬀerence in the usage volume
of antimicrobials, resulting in the biased prevalence of
antimicrobial resistance among animal species.
2.4. The Trend in Antimicrobial Resistance in Commensal E.
coli Isolates from Food-Producing Animals from Japan and
Other Countries. The prevalence of antimicrobial resistance
in commensal E. coli isolated from food-producing animals
has been monitored in several countries including Japan.
Here, the current trends in rates of resistance to older
antimicrobials including penicillin, streptomycin, and tetra-
cycline and newer antimicrobials including third-generation
cephalosporins and ﬂuoroquinolones among countries are
summarized in Table 1(a) (cattle), Table 1(b) (pigs), and
Table 1(c) (broilers).
Overall comparison of resistance rates against older
antimicrobials including penicillin, streptomycin, and tetra-
cycline revealed signiﬁcant diﬀerences between countries.
Isolates from all species in Sweden and Norway, and from
cattle and broilers in Finland tended to show a lower preva-
lence of resistance than those in the other countries, which
mayhaveresultedfromthecomparativelyloweroverallusage
of therapeutic antimicrobial compounds (approximately
17.2t, 6.5t, and 14.1t in 2006, resp.) [26, 39]. On the other
hand, isolates from all species in Japan showed moderate
prevalence of resistance among countries. Considering the
usage volume of antimicrobials, the resistance levels in Japan
have been kept relatively low. In most countries, tetracycline
resistance tended to be more prevalent than resistance to
penicillin and streptomycin in all species. In Denmark,
Norway, and Sweden, however, the prevalence of resistance
to penicillin and/or streptomycin were equal to or more than
that of tetracycline resistance.
Among animal species, bovine isolates exhibited gener-
allylowerlevelsofresistancetoolderantimicrobialsthaniso-
lates from the other two species in most countries including
Japan, with the exception of isolates from the Netherlands,
where lower prevalence of resistance was observed in porcine
isolates. This may suggest that antimicrobial usage for cattle
tends to be less common in most countries, although there
are variations in the degree of absolute usage volume among
countries as described above.
The resistance to ﬂuoroquinolone has essentially
remained at low levels irrespective of countries or animal
species. This may be explained by the attributive period
of ﬂuoroquinolone use because the agent was recently
available in veterinary medicine. However, relatively high
prevalence of resistance has been already observed in broilers
in the Netherlands, Spain, and Korea and cattle in the
Netherlands. The ﬂuoroquinolone drugs are regarded as
critically important antimicrobials in human and animal
medicine internationally [13], and thus, the trend of its
resistance would need continuous and careful observation.
The variation in antimicrobial resistance between dif-
ferent countries may be attributable to the quantity of
the antimicrobial used, the time over which it had been
available, the route or dosage by which it was administered,
or some other epidemiological factors [30]. However, it
remains possible that the variation between countries also
includes disparities in monitoring methodologies [40]. In
particular, older antimicrobials have been traditionally used
as ﬁrst-line drugs in veterinary medicine in a number
of countries worldwide, and therefore, their resistance
may greatly reﬂect country-speciﬁc antimicrobial usage. In
response to the present state of resistance prevalence in each
country, country-speciﬁc risk management would therefore
be needed.
3. Occurrence of AntimicrobialResistance
IncludingCross-Resistanceand
CoresistanceunderSelectivePressure
It is known that the application of a single drug may
result not only in direct selection of the corresponding
resistance but also in development of cross-resistance (the
resistances to several structurally-related antimicrobials) and
coresistance (the resistances to several structurally-unrelated
antimicrobials), via speciﬁc resistance mechanisms [2, 41].
Some reports from the JVARM demonstrated the rela-
tionship between therapeutic antimicrobial use and the
occurrence of bacterial antimicrobial resistance at a farm
level.
3.1.DirectandIndirectSelectionsofResistantE.coliduetoOn-
Farm Use of Antimicrobial Drugs. To clarify the actual selec-
tions of resistance by veterinary antimicrobial use, a large-
scale epidemiological study was carried out by examining
the rates of resistance to several antimicrobials among com-
mensal E. coli isolates from pig herds with diﬀerent histories
of antimicrobial drug use [42]. Comparative analysis with
the non-antimicrobial-exposed herd revealed that the rate of
ampicillinresistanceincreasedintheherdsthatwereexposed
to penicillin and penicillin-streptomycin; the rate of dihy-
drostreptomycin resistance, in the penicillin-streptomycin-
exposed herd; and the rate of trimethoprim resistance,
in the methoprim-sulfonamide-exposed herd. Accordingly,
each class of resistance was found more frequently in the
herds exposed to the same antimicrobial classes than in
those exposed to other antimicrobial classes (Figure 4).
In the previous national-level analysis, the antimicrobial
resistance rate of each class is correlated with the overall
sales volume of the same antimicrobial class [14]. Thus, the
use of the same class of antimicrobials, which can selectJournal of Biomedicine and Biotechnology 5
Table 1
(a) Current trends in rates (%) of resistance to selected antimicrobials in commensal E. coli isolates from cattle
Country Survey year PCa SMb TCc FQd References
Japane 2007 9.2 19.2 26.2 1.5 [20]
United Statesf 2002-2003 2.5 10.2 23.1 NT [21]
Canada 2005 2.5 7.4 22.1 0.0 [22]
Denmark 2006 2.2 10.8 9.7 0.0 [23]
France 2004 14.0 20.0 26.0 0.0 [24]
Norway 2005 2.0 9.2 1.0 0.0 [25]
Sweden 2006 0.0 2.0 2.0 <1.0 [26]
UKf 2004 3.0 2.0 6.0 NT [27]
Netherlands 2005 48.5 NT 82.4 25.5 [28]
Finland 2006 <1.0 3.0 <1.0 1.0 [29]
Italy 1999–2001 14.3 15.3 19.6 2.1 [30]
Germany 1999–2001 1.7 3.7 6.5 0.0 [30]
Australia 2003-2004 0.0 NT 3.0 0.0 [31]
Koreaf 2003-2004 12.0 20.4 30.5 0.6 [32]
aPC, penicillin antibiotics including ampicillin (MIC breakpoints, 16–32mg/L) and amoxicillin (16mg/L).
bSM, streptomycin antibiotics including streptomycin (16–64mg/L) and dihydrostreptomycin (32mg/L).
cTC, tetracycline antibiotics including tetracycline and oxytetracycline (16mg/L).
dFQ,ﬂuoroquinoloneagentsincludingciproﬂoxacin(0.125–4mg/L)andenroﬂoxacin(0.125–2mg/L).Inparticular,someEuropeancountrieslikeDenmark,
Norway, Sweden, Netherlands, and Finland adopted low MIC breakpoints between 0.125 and 1.0mg/L.
eIn Japan, ampicillin, dihydrostreptomycin, oxytetracycline, and enroﬂoxacin were used as the representative of PC, SM, TC, and FQ, respectively, for
susceptibility testing. As for ampicillin, the MIC breakpoint established by the Clinical Laboratory Standards Institute was adopted (32mg/L) [33]; for
the remaining antimicrobials, MIC breakpoints were set as the midpoint between the peaks of each MIC distribution (dihydrostreptomycin, 32mg/L;
oxytetracycline, 16mg/L; enroﬂoxacin, 2mg/L) [34].
fSusceptibility tests for all antimicrobials were performed by disk diﬀusion method.
(b) Current trends in rates (%) of resistance to selected antimicrobials in commensal E. coli isolates from pigs
Country Survey year PCa SMb TCc FQd References
Japane 2007 22.6 43.4 57.5 0.0 [20]
United Statesf 2002-2003 18.8 30.6 63.1 NT [21]
Canada 2005 34.6 38.9 74.7 0.6 [22]
Denmark 2006 20.3 40.5 28.4 0.7 [23]
France 2004 22.0 62.0 86.0 1.0 [24]
Norway 2004 8.0 33.6 9.6 0.0 [35]
Sweden 2005 6.0 14.0 9.0 <1.0 [26]
UKf 2004 28.0 28.0 80.0 NT [27]
Netherlands 2005 30.4 NT 61.9 0.0 [28]
Spainf 2005 60.9 63.5 90.1 4.2 [36]
Australia 2003-2004 35.0 NT 76.0 0.0 [31]
Korea 2001–2003 75.2 85.7 99.2 7.5 [37]
Chile 2003 NT 84.0 96.0 6.0 [38]
aPC, penicillin antibiotics including ampicillin (MIC breakpoints, 16–32mg/L) and amoxicillin (16–32mg/L).
bSM, streptomycin antibiotics including streptomycin (16–64mg/L) and dihydrostreptomycin (32mg/L).
cTC, tetracycline antibiotics including tetracycline and oxytetracycline (16mg/L).
dFQ,ﬂuoroquinoloneagentsincludingciproﬂoxacin(0.125–4mg/L)andenroﬂoxacin(0.125–2mg/L).Inparticular,someEuropeancountrieslikeDenmark,
Norway, Sweden, and Netherlands adopted low MIC breakpoints between 0.125 and 1.0mg/L.
eIn Japan, ampicillin, dihydrostreptomycin, oxytetracycline, and enroﬂoxacin were used as the representative of PC, SM, TC, and FQ, respectively, for
susceptibility testing. As for ampicillin, the MIC breakpoint established by the Clinical Laboratory Standards Institute was adopted (32mg/L) [33]; for
the remaining antimicrobials, MIC breakpoints were set as the midpoint between the peaks of each MIC distribution (dihydrostreptomycin, 32mg/L;
oxytetracycline, 16mg/L; enroﬂoxacin, 2mg/L) [34].
fSusceptibility tests for all antimicrobials (the United States and UK) or streptomycin (Spain) were performed by disk diﬀusion method.6 Journal of Biomedicine and Biotechnology
(c) Current trends in rates (%) of resistance to selected antimicrobials in commensal E. coli isolates from broilers
Country Survey year PCa SMb TCc FQd References
Japane 2007 42.2 43.1 53.9 5.9 [20]
United Statesf 2002-2003 2.1 15.1 35.1 NT [21]
Canada 2005 38.5 43.1 57.3 0.0 [22]
Denmark 2006 17.1 10.6 6.5 5.7 [23]
France 2004 37.0 39.0 73.0 4.0 [24]
Norway 2006 13.2 2.1 3.7 1.1 [39]
Sweden 2004 4.0 6.0 6.0 2.0 [26]
UKf 2004 37.0 NT 65.0 6.0 [27]
Netherlands 2005 63.5 NT 60.9 50.8 [28]
Spainf 2005 64.0 51.0 68.0 53.0 [36]
Finland 2005 16.0 7.0 17.0 1.0 [29]
Australia 2003-2004 33.0 NT 44.0 0.4 [31]
Korea 2001–2003 63.8 86.5 80.4 50.1 [37]
Chile 2003 NT 57.1 80.6 28.5 [38]
aPC, penicillin antibiotics including ampicillin (MIC breakpoints, 16–32mg/L) and amoxicillin (16–32mg/L).
bSM, streptomycin antibiotics including streptomycin (16–64mg/L) and dihydrostreptomycin (32mg/L).
cTC, tetracycline antibiotics including tetracycline and oxytetracycline (16mg/L).
dFQ,ﬂuoroquinoloneagentsincludingciproﬂoxacin(0.125–4mg/L)andenroﬂoxacin(0.125–2mg/L).Inparticular,someEuropeancountrieslikeDenmark,
Norway, Sweden, Netherlands, and Finland adopted low MIC breakpoints between 0.125 and 1.0mg/L.
eIn Japan, ampicillin, dihydrostreptomycin, oxytetracycline, and enroﬂoxacin were used as the representative of PC, SM, TC, and FQ, respectively, for
susceptibility testing. As for ampicillin, the MIC breakpoint established by the Clinical Laboratory Standards Institute was adopted (32mg/L) [33]; for
the remaining antimicrobials, MIC breakpoints were set as the midpoint between the peaks of each MIC distribution (dihydrostreptomycin, 32mg/L;
oxytetracycline, 16mg/L; enroﬂoxacin, 2mg/L) [34].
fSusceptibility tests for all antimicrobials (the United States and UK) or streptomycin (Spain) were performed by disk diﬀusion method.
the corresponding resistance and cross-resistance, strongly
contributes to building the speciﬁc resistant population at
the farm level and national level.
On the other hand, the rates of resistances to ampi-
cillin, dihydrostreptomycin, kanamycin, and trimethoprim
increased in the tetracycline-exposed herd and the rates
of oxytetracycline and kanamycin resistances increased in
the penicillin-streptomycin-exposed herd (Figure 4). These
results raised the probability that the use of tetracycline
or penicillin-streptomycin antibiotics contributed to the
selection of other resistances linking resistance to the antimi-
crobials used, and that the tetracycline use could coselect
for the most extensive resistances in commensal E. coli
isolates of pig origin. Annual reports reveal that tetracyclines
have been used in the largest quantities in Japan [11], and
therefore, tetracycline resistance has been the most prevalent
in E. coli of pig origin [43, 44]. In addition, Sunde and
Norstr¨ om [45] demonstrated the cotransfer of determinants
of resistances to tetracycline and other antimicrobials via
plasmids in E. coli isolated from meat products. Thus, the
coselective force imposed by tetracycline use would likely
have a signiﬁcant impact on the prevalence of resistance to
extensiveantimicrobialsinE.coliinfood-producinganimals.
Generally, coselection is closely associated with coresis-
tance that is encoded by diﬀerent resistance determinants
gathered on a single mobile genetic element including
plasmidandtransposon[2,41].Thissuggeststhatresistances
acquired by chromosomal mutation of the target site, such
as quinolone resistance, are diﬃcult to be coselected by
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Figure 4: Relative risks of antimicrobial resistance in porcine E. coli
isolates due to exposure to antimicrobials mainly used in Japan.
aSymbols indicate the values of relative risk of each resistance due
to exposure to tetracycline antibiotics ( ), penicillin antibiotics (),
methoprims-sulfonamides combination drugs (), and penicillin-
streptomycin combination drugs (). ∗In case that 95% conﬁdence
interval ( ) does not include the value 1, the relative risk is
considered statistically signiﬁcant (P<. 05). This ﬁgure is based on
the data obtained from the previous manuscript mentioned in [42].
use of other antimicrobials. The farm-level monitoring
data of Campylobacter, however, raised the possibility that
ﬂuoroquinolone-resistant isolates with multi-antimicrobial
resistance have been coselected by use of the antimicrobials
included by their resistance pattern like tetracyclines [46].Journal of Biomedicine and Biotechnology 7
Thus,evenresistanceacquiredbygenemutationcanbecose-
lected through multiple-antimicrobial resistance in bacteria.
The direct selection of the corresponding resistance
and indirect selection via cross-resistance and coresistance
signiﬁcantly can contribute to the farm-level prevalence of
antimicrobial-resistant bacteria. In indirect selection, the use
of antimicrobials can select cross-resistance more greatly
than coresistance in bacteria. Thus, the antimicrobial drugs
classiﬁed into the same class as important drugs should
be actively controlled. On the other hand, it may also
be necessary that special attention is given to the use of
antimicrobial drugs that can cause coselection to further
minimize the prevalence of antimicrobial-resistant bacteria.
3.2. Contribution of Coselection to the Persistence of Resistance
to Speciﬁc Antimicrobials in the Absence of Selective Pressure.
In Japan, the use of several antimicrobials in food-producing
animals was banned because of human health issues posed
by their toxic eﬀects. In particular, the use of carbadox
was banned in 1997, followed by the ban on frazolidone,
difurazon, and chloramphenicol in 1998. It is believed that
the ban of antimicrobial use will help prevent the develop-
ment of antimicrobial resistance in bacteria. However, in the
absenceofselectivepressure,speciﬁcantimicrobialresistance
becomes prevalent in food-producing animals.
The JVARM study showed that 40.6% of E. coli isolated
from diseased animals was resistant to chloramphenicol after
thebanofitsuse[16].Bythefurtherdetailedinvestigation,it
was clariﬁed that strains with the chloramphenicol resistance
genes that were isolated from diseased cattle often were
resistanttoampicillin,dihydrostreptomycin,oxytetracycline,
and trimethoprim, and those that were isolated from dis-
eased pigs were often resistant to dihydrostreptomycin and
trimethoprim. Class 1 integrons, which were responsible
for resistance(s) to streptomycins, methoprims, or both,
were more prevalent in strains with than those without
the chloramphenicol resistance genes. Therefore, selective
pressureimposedbytheuseofothercommonantimicrobials
may contribute to the coselection of chloramphenicol-
resistant E. coli in Japan. Bischoﬀ et al. [47] conﬁrmed that
resistance to sulfamethoxazole, tetracycline, and kanamycin
frequentlytransferredalongwithchloramphenicolresistance
through genetic linkage between their resistance genes in
porcine E. coli isolates, and suggested that chloramphenicol
resistance has been maintained by the use of antimicrobials
that are currently approved, as well as our presumption.
These ﬁndings suggest the possibility that, even in the
absence of speciﬁc selective pressure due to the use of
phenicols, chloramphenicol resistance remains so long as
other antimicrobials are used in food-producing animals.
For resistance to antimicrobials other than chloram-
phenicol, coselection contributes to the persistence in
the absence of selective pressure. In Japan, while no
cephalosporins are approved for use in poultry, cefazolin-
resistant E. coli strains, which harbored extended-spectrum
class A or class C β-lactamase on plasmid, have been
isolated from broiler chickens [48]. These β-lactamase genes
were transferred with other antimicrobial resistance genes,
suggesting that expended-spectrum β-lactamase producing
E. coli are currently maintained by other antimicrobial use.
Other studies clariﬁed that plasmids with resistances to
carbadox and the other drugs were prevalent in porcine
E. coli isolates [49], and thus carbadox-resistant isolates
c a nc o n t i n u et ob ec o s e l e c t e da f t e rt h eb a no fc a r b a d o x .
For enterococci, Bager et al. [50] showed the persistence
of glycopeptide-resistant enterococci in Danish pigs after
the ban of the use of avoparcin. It is suggested that the
glycopeptide resistance gene in swine enterococcal strains
was selected by the use of macrolides via cotransfer with
macrolide resistance genes [51].
It is suggested that the withdrawal of antimicrobials in
order to decrease rates of resistance is not always an eﬀective
strategy for restoration of the therapeutic eﬀectiveness of
a speciﬁc drug. Simultaneous reductions in the selection
pressures of coselecting agents may be required to reduce
the emergence, spread, and persistence of antimicrobial
resistance in the animal production environment.
4.Associationof AntimicrobialResistance
Proﬁle with BacterialProperties
The pathogenicity of bacteria, including E. coli,i so f t e n
characterizedbyintrinsic properties suchasvirulencefactors
and serotypes. Clinical signs, being associated with the
pathogenic properties of bacteria, may aﬀect the scenario
of antimicrobial treatment. Information on antimicrobial
resistance in animal bacterial pathogen is therefore helpful
not merely for adequate selection and prudent use of
antimicrobialagentsinveterinarymedicinebutalsocompre-
hension about the relationship between bacterial properties
and antimicrobial resistance proﬁle.
4.1. The Prevalence of Antimicrobial Resistance in Pathogenic
E. coli. Antimicrobial susceptibilities in pathogenic E. coli
isolates from diseased animals with colibacillosis were
investigated under the JVARM. In particular, resistance to
commonly used antimicrobials, including ampicillin, dihy-
drostreptomycin, and oxytetracycline, was highly prevalent
in the isolates from diseased animals [52, 53]. Compared
with commensal E. coli isolates from apparently healthy
animals [17], those from diseased animals showed higher
rates of resistance to most or some of the antimicrobials
tested. Similarly, in the DANMAP report [23], higher
prevalence of resistance was observed in E. coli isolated
from diagnostic submissions compared to the bacterium
from healthy animals. On the whole, the pathogenic isolates
from diseased animal are likely to have greater resistances,
which may be a consequence of antimicrobial treatment in
veterinary medicine.
Pathogenic E. coli can be characterized by their spe-
ciﬁc pathogenic mechanisms like toxins, adhesins, and
invasiveness [54]. In particular, shiga toxins-producing E.
coli (STEC) and enterotoxigenic E. coli (ETEC) have been
implicated in a number of speciﬁc diseases in animals [55].
Under the JVARM, resistance to colistin and enroﬂoxacin
was more prevalent in STEC isolates, mainly harboring stx2e8 Journal of Biomedicine and Biotechnology
gene, than in non-STEC isolates from diseased pigs [52].
Meanwhile, there was no relationship between antimicrobial
resistance prevalence and virulence factors tested in the
isolates from diseased cattle and chickens [52, 53].
On the other hand, Boerlin et al. [56] conﬁrmed that
resistance to most antimicrobials tested was higher in ETEC
than in non-ETEC isolates from pigs with diarrhea in
Ontario and that statistically positive association existed
between resistance genes for tetracycline, sulfonamides, and
apramycinandmajorvirulencegenesincludingelt,estA,estB,
faeG,paa,andsepA.Inaddition,substantiallinkagesbetween
antimicrobialresistancegenesandspeciﬁcvirulencegeneson
large transferable plasmids have been described occasionally
in the past for ETEC isolates from swine and calves [57–60]
and for APEC [61] in several countries. These data indirectly
or directly suggest the relationship between virulence and
resistance genes.
Higher prevalence of antimicrobial resistance in
pathogenic bacteria can be primarily explained by the
possible contribution of increased selective pressure by
repeated exposure to therapeutic agents. In addition, strong
relationship between resistance and virulence factors also
likely contributes to the spread of antimicrobial resistance
among pathogenic bacteria. These facts should be taken
into account in risk management for antimicrobial-resistant
bacterial pathogen in veterinary medicine.
4.2. Prevalence of Antimicrobial Resistance among Serotypes of
Bacteria. Serotyping is used extensively to categorize strains
of E. coli. There are 174 O antigens and 53 H antigens in the
international serotyping scheme, with E. coli isolates having
various combinations of O and H antigens [55]. However,
data on the relationship between antimicrobial resistance
proﬁles and serotypes in E. coli are still limited.
Under the JVARM, there are some ﬁndings about the
association with serotypes. In the survey of STEC in cattle, it
was shown that multiple resistance was relatively frequently
observed in certain serotypes like O2:NM, O26:H11/NM,
O145:NM, and O174:NM/H21, which are nonpathogenic
for animals [62]. In addition, the ﬁeld study on APEC
showed that more than half of enroﬂoxacin-resistant strains
belonged to serotype O78, which is one of the most common
serotypes in APEC, with a similar genotype [53]. In Europe,
it is reported that the STEC O118:H16/NM strains with
multi-antimicrobial resistance have spread clonally in cattle
and humans [63].
For other bacterial species, Salmonella serovars Dublin,
Typhimurium and Choleraesuis are regarded as serotypes
causing salmonellosis in farm animals. These serotypes,
harboring the speciﬁc plasmid responsible for virulence in
mice [64], commonly have high frequency of resistance to
antimicrobials like ampicillin, streptomycin, and tetracycline
[65–68]. Other serotypes like Infantis and Schwarzengrund
have relatively low pathogenicity for farm animals, but
exhibit the speciﬁc resistance patterns [69–71]. In addition,
in Campylobacter jejuni, biased prevalence of antimicrobial
resistance has also been observed among serotypes, although
the bacterium is usually not pathogenic in animals [72].
The dissemination of serotypes with characteristic resis-
tance proﬁles could be a factor biasing the antimicrobial
resistance prevalence in bacteria. However, there are not
enough evidences to fully comprehend the causal associa-
tion between serotypes and antimicrobial resistance proﬁle
in bacteria. The trend of antimicrobial resistance among
serotypesinbacteriashouldbethereforemonitoredcarefully.
5. FutureIssue
Several countries have already launched national level mon-
itoring for risk analysis of antimicrobial resistance in food-
producing animals. In some countries, veterinary use of
some antimicrobials is regulated by new decisions such as
ban of ﬂuoroquinolone use in poultry in the United States,
and antimicrobial growth promoter in European Union.
National level monitoring helps to realize broad prevalence
of antimicrobial resistance: however, it is unable to fully
ﬁgure out variability of antimicrobial resistance prevalence
among farms or among herds and individuals on a farm.
Detection of antimicrobial-resistant bacteria on farms usu-
ally means that the bacteria have developed antimicrobial
resistance by genetic mutations or acquisition of resistance
genes [41], and other resistant clones have intruded into
the farms [73]. In either case, the use of antimicrobials
frequently acts as selective force. In addition, occurrence
and prevalence of antimicrobial resistance were aﬀected by
multiple factors including feeding system and practices on
farms [74–77], age [74, 78, 79], pharmacodynamics [80],
stress [81, 82], and commensal ﬂora [83] for individuals.
Such investigation on farm-level epidemiology to proﬁle risk
of development of antimicrobial resistance is important for
controlling antimicrobial resistance on farms.
At present, national level monitoring is limited to
elucidate all of the factors that contribute to antimicro-
bial resistance prevalence. In Japan, as described in this
review, contradictory results between antimicrobial resis-
tance prevalence and antimicrobial use are obtained in
the national veterinary monitoring. Especially, resistance to
critically important antimicrobials such as ﬂuoroquinolones
and cephalosporins [13] may need to be preferentially
monitored not only at national level but also on farm or
at individual level for making assured risk management
decisions. Hereafter, further detailed monitoring may be
implemented in veterinary ﬁeld. The following steps are
recommended: (1) national (or district) level monitoring,
(2) farm level monitoring, and (3) individual (or herd)
level monitoring. These eﬀorts will develop conservative risk
management strategies of antimicrobial resistance.
6. Conclusion
Multiple factors appear to participate in the occurrence
and prevalence of antimicrobial-resistant bacteria under the
selective pressure from antimicrobial usage. It is supported
by the national-level and farm-level data that the direct
resistance selection or indirect selection via cross-resistance
greatly contributes to antimicrobial resistance prevalence.Journal of Biomedicine and Biotechnology 9
In other words, the prevalence of a speciﬁc resistance can
be controlled by the regulation of the corresponding class
of antimicrobial drug. Such a strategy probably leads to
a successful outcome. On the other hand, the aﬀection of
coresistance may lead to unexpected results. Without the
knowledge on actual magnitude of coresistance, judicious
regulationoftheusageofalltheantimicrobialsthatcanselect
the resistance might be needed to control coresistance. This
direction involves issues that greatly threaten animal health
and welfare. Therefore, the risk manager should initially
collect practical data on the eﬀect of coresistance, and select
the risk management option to balance cross-resistance and
coresistance.
Moreover, the JVARM data, which may be limited, sug-
gested that the bacterial property like virulence factors and
serotypes sometimes aﬀect the prevalence of antimicrobial
resistance in E. coli and other bacterial species of animal
origin. However, the relationship between these factors
and resistance has been inconsistently reported by each
researcher, and thus it would be needed to continue to
carefully monitor its relationship in addition to other known
bacterial properties like intrinsic ﬁtness [84–86].
Finally, this paper ﬁrst revealed current situation of vet-
erinary antimicrobial usage and prevalence of antimicrobial-
resistant E. coli isolates from food-producing animals in
Japan. In addition, the contributing factors, mainly antimi-
crobial selective pressure, were described based on hitherto
obtained data. It is hoped that this paper will assist an
understandingofepidemiologyofantimicrobialresistanceas
much as possible.
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